Literature DB >> 23340554

Eighteen months of "matching Michigan" at a UK neonatal intensive care unit.

Sarah Montgomery-Taylor1, Faith Emery, Mark Anthony.   

Abstract

Our "Matching Michigan" program has 3 focuses for identifying and reducing nosocomial infection. First, practical training to optimize infection control; second, root cause analysis of blood-culture positives; and third, feedback and use of results to develop new guidelines. Our infection rates are comparable with adult units. Interventions have reduced coagulase-negative staphylococcal infections whereas other infection rates have reduced relative to increased activity.

Entities:  

Mesh:

Year:  2013        PMID: 23340554     DOI: 10.1097/INF.0b013e3182868389

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  3 in total

Review 1.  Neonatal severe bacterial infection impairment estimates in South Asia, sub-Saharan Africa, and Latin America for 2010.

Authors:  Anna C Seale; Hannah Blencowe; Anita Zaidi; Hammad Ganatra; Sana Syed; Cyril Engmann; Charles R Newton; Stefania Vergnano; Barbara J Stoll; Simon N Cousens; Joy E Lawn
Journal:  Pediatr Res       Date:  2013-12       Impact factor: 3.756

2.  Safety and efficacy of 2% chlorhexidine gluconate aqueous versus 2% chlorhexidine gluconate in 70% isopropyl alcohol for skin disinfection prior to percutaneous central venous catheter insertion in preterm neonates: the ARCTIC randomised-controlled feasibility trial protocol.

Authors:  Paul Clarke; Jean V Craig; John Wain; Catherine Tremlett; Louise Linsell; Ursula Bowler; Ed Juszczak; Paul T Heath
Journal:  BMJ Open       Date:  2019-02-19       Impact factor: 2.692

3.  Linking surveillance and clinical data for evaluating trends in bloodstream infection rates in neonatal units in England.

Authors:  Caroline Fraser; Berit Muller-Pebody; Ruth Blackburn; Jim Gray; Sam J Oddie; Ruth E Gilbert; Katie Harron
Journal:  PLoS One       Date:  2019-12-12       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.